Phosphoethanolamine is a drug that has been studied by the University of São Paulo (USP) since the 1980s. Although the research was not focused on the treatment of cancer, it was perceived that this substance has anticancer action. Therefore, research and testing in laboratory animals has begun to evaluate its action against tumors.
Controversy
The use of this drug in humans has been causing a lot of confusion because there is strong social pressure for it to be approved.
The main issues regarding Phosphoethanolamine are: lack of scientific validation and political interference.
Lack of scientific validation
For any drug, treatment, or substance that is developed, a protocol must be followed. It requires that several tests and research be done to be validated by the scientific community.
Phosphoethanolamine only went through the animal testing stage. No tests were performed on people to know how the drug would behave in the human body. Therefore, it could not have its distribution authorized.
Political Interference
Although there is no validation that the drug is effective and safe for use in humans, the Senate has approved its distribution, yielding to social pressure.
Dr. Drauzio Varella, said on video to his portal that every time politics goes over science problems happen. He says this because the Deputies and Senators have taken a rash attitude, removing the authority of ANVISA, the agency responsible for releasing or not new medicines.
Source: Drauzio Varella Portal